Navigation Links
VaxGen Files First Quarter 2007 Financials
Date:9/21/2007

SOUTH SAN FRANCISCO, Calif., Sept. 21 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN) announced today that it has filed with the Securities and Exchange Commission (SEC) its Quarterly Report on Form 10-Q for the quarter ended March 31, 2007. The report can be found at the link titled "SEC Filings" in the Investor Relations section of VaxGen's web site at http://www.vaxgen.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)

The only financial statements the company has outstanding before it regains compliance with its SEC financial reporting obligations are the Quarterly Report on Form 10-Q for the quarter ended June 30, 2007, which is currently under review by VaxGen and its independent auditors. Once VaxGen is current with its financial statements, the company intends to apply for listing on a national stock exchange.

About VaxGen

VaxGen is a biopharmaceutical company based in South San Francisco, California. For more information, please visit the company's web site at http://www.vaxgen.com.

Note: This press release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the anticipated filing of the company's outstanding quarterly reports and its application for listing of its common stock. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. VaxGen undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the d
'/>"/>

SOURCE VaxGen
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PCR Polymerases Application Profiles
2. RNAlater Preserves Bacterial Gene Expression Profiles for Array Analysis
3. Obtaining a contour map from multifiles or 3D data in DataMax
4. Successful stabilization of gene expression profiles
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Third Wave files countersuit vs. Digene in patent case
7. TomoTherapy files registration statement for IPO
8. Merge files financial reports by market opening
9. The Why Files celebrates decade of science exploration
10. Third Wave files patent suits against Digene, Chiron and Bayer
11. New Web virus could lead to lost files, extortion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IK,Iceland,November24/PRNewswire-FirstCall/--deCOD...hasreceivednoticefrom,theNasdaqStockMarketthattrad...vember30,2009andaForm25-NSEwillbefiledwiththe,Secu...scommonstock,fromlistingonNasdaq,unlessthecompanyf....Thecompanyhasfiledsuchanappeal,which,willstaythes...
(Date:11/24/2009)... Health care employment grew by 29,000...ne to show consistent growth during the U.S. reces...ain in trouble, and health systems are coming clos...stead of just administrators. , ...ployment continued growing in October despite the ...
(Date:11/24/2009)...I,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.a...lowedthepatentapplicationfor,itsnano-particleorald...hlyefficientapproachtoincorporatepeptidesor,protei...ryofdrugs,otherwiseadministeredasinjections.NODtec...ymacromoleculardrugssuchasinsulin,interferon,grow...
(Date:11/24/2009)...I,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannounce...hasapprovedthe,investigationalnewdrugapplication(I...nsulinformulationtotreatdiabetes.ThisIND,approvala... , Diabetesisadisordercharacteristicofhighblo...etesoftenresultinseveremicro-and,macro-vasculardis...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...ollowing was issued,today by the Greater Baltimore...O, Greater Baltimore Committee, 140 company owner...rea,bioscience community, WHAT:, The third annua...N:, Tuesday, March 18, 2008, 8:00 a.m. / Breakfa...ram, WHERE:, Renaissance Harborplace Hotel, 202 ...
...rocess, Drive Value from Appraisals, OTTAWA, Marc...ng,provider of web-based employee performance and ... has been selected by Quiznos to provide a system,...adquarters. Quiznos is a,national chain with over ...usy consumers who are looking for a tasty, fresher...
...d Support of National Electronic Disease ...Calif., March 17 Computer,Sciences Corporation (N...ed a,task order from the Centers for Disease Contr... supporting the National Electronic Disease,Survei...m helps the CDC,manage and enhance public health s...
Other Biology Technology:Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18 2Quiznos Selects Halogen for Fresh Approach to Talent Management 2CSC Continues Support of Centers for Disease Control and Prevention Through New Task Order 2
(Date:11/25/2009)... may be just as vital to your health as what you e...ological Studies. Their experiments in mice reveal...f genes in the liverthe body,s metabolic clearingh... the body,s circadian clock as conventional wisdom...vity of a large number of genes completely indepen...
(Date:11/24/2009)...and flabby arteries from collapsing have been true...re no longer needed -- once the arteries are stren...ors had no choice but to leave them in place. , ...partment of Biomedical Engineering has developed a...ugs where they,re needed, then dissolves. , "Our...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 1AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 2AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 14439 3DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 1DC 3A Muslim Coalition to Host Interfaith Hearing on Health Care 59326 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 1Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 4Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 5Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 6Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 7Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt 28TM 29 in the U S and Canada fo 5409 8
...g bones, a healthy immune system, protection again...ere,s yet another item for the expanding list of v...n," keeps the heart, the body,s long-distance runn...gan pharmacologist Robert U. Simpson, Ph.D., think...er." , In studies in rats, Simpson and his team ...
...11, 2008 The J. David Gladstone Institutes today ..., MD, PhD, also of Kyoto University and UCSF, has ...ntributions in reprogramming adult skin cells to p...eive half of the $1 million award. Cloning pioneer...er half of the prize for their landmark generation...
...ational May Concern Law Enforcement Departments, ...ulletin Board: STIY), the leader in electro-stun t...sting law enforcement departments that,have purcha...ade their,weapons in for Stinger S-200 electronic ...ssions., Ron Bellistri, Stinger,s CEO, stated, "I...
Other Biology News:Vitamin D: New way to treat heart failure? 2Vitamin D: New way to treat heart failure? 3Gladstone's Shinya Yamanaka wins prestigious Shaw Prize 2Stinger Systems To Offer Taser Trade-In Program 2
Mouse Anti-Xanthine Oxidase Prediluted Monoclonal Antibody, Unconjugated, Clone SPM325 from Abcam
Mouse Anti-Vancomycin Monoclonal Antibody, Unconjugated, Clone 2G1 from Abcam
Mouse Anti-14-3-3 Binding Motif, phospho (Ser) Monoclonal Antibody, Unconjugated, Clone 4E2 from Cell Signaling Technology
Endotoxin Free Water from Mo Bio Laboratories, Inc.
Biology Products: